Chiral separation of Carbinoxamine (2-[(4-Chlorophenyl)-Pyridin-2- yl-Methoxy]-N,N-Dimethyl-Ethanamine)

Importance of the Topic

Carbinoxamine is a widely used antihistamine with chiral centers, making enantiomeric purity crucial for its therapeutic efficacy and safety.

Goals and Study Overview

The study aimed to develop a robust chiral HPLC method for the baseline separation of Carbinoxamine enantiomers using a cellulose-based stationary phase under isocratic conditions.

Methodology and Instrumentation

The method employed a Eurocel 01 column with specific mobile phase composition and detection parameters to achieve efficient chiral resolution.

• Column: Eurocel 01, 5 µm, 250 × 4.6 mm ID
• Mobile Phase: n-Heptane/2-Propanol (90:10) with 0.1% diethylamine
• Flow Rate: 1.0 mL/min
• Temperature: 25 °C
• Injection Volume: 10 µL
• Detection: UV at 230 nm

Main Results and Discussion

The method yielded retention factors k′1 = 1.69 and k′2 = 1.94, corresponding to an enantioselectivity (α) of 1.14, indicating clear baseline separation of the two enantiomers. The stable isocratic conditions ensured reproducible retention times and peak shapes.

Benefits and Practical Applications

The developed method offers:

• Reliable enantiomeric purity assessment for quality control in pharmaceutical production
• Regulatory compliance support through precise chiral analysis
• Applicability for research and development of new antihistamine formulations

Future Trends and Potential Applications

Advancements may include greener solvent systems, integration with mass spectrometry for trace-level detection, and high-throughput screening platforms using similar chiral selectors to broaden analytical capabilities.

Conclusion

The chiral HPLC method on a cellulose-based Eurocel 01 column proved effective for separating Carbinoxamine enantiomers with good resolution and reproducibility, making it a valuable tool for pharmaceutical analysis.